| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Leap Therapeutics shares are plunging after rebranding as Cypherpunk, pivoting to a Zcash treasury and announcing a $200M stock...
Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0...